BREAST REDUCTION DECREASING COMPLICATION WITH PARENCHYMAL SUTURES: AN ORIGINAL RESEARCHSaravananRavindran, P.Rajkumar M. Ch, C.Sowmya T. K.Arumugam, AnandJournal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research)
At ASCO, the results of the weight reduction [portion] were formally presented, and they’re exciting, showing that additional support for breast cancer survivors can lead to significant reductions in weights that can be sustainable. We eagerly await continued follow-up of this trial [to see...
According to preclinical studies and a retrospective clinical analysis, the menstrual cycle may influence the breast cancer response to neoadjuvant chemotherapy — suggesting that treatment could be timed for optimal outcomes. Karen O’Leary Research Highlight15 Jan 2025 ...
Recent studies have indicated that particular miRNA signatures are correlated with tumor aggressiveness, response to drug therapy and patient outcome in breast cancer. On the other hand, in routine clinical practice, the treatment regimens for breast cancer are determined based on the intrinsic subtype...
In general, multipronged programs had a higher range for dose reduction (22%-74%), followed by policy/ structural interventions (37%-50%). Conclusions: Existing evidence on the effectiveness of policies aimed at reducing patient radiation dose is disperse and low in quality. Compared with other...
Chen Y, Thompson W, Semenciw R, Mao Y (1999) Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8:855–861 PubMed CAS Google Scholar Hennedige AA, Kong TY, Gandhi A (2009) Oncological screening for bilateral breast reduction: a survey of practice variations in UK...
Breast cancer is composed of a heterogeneous group of diseases which is characterized by differences in genetic mutations/aberrant oncogene expression, histopathological types, and metastatic potentials. Animal models are valuable tools for defining the
Two subjects were primiparous, and parity was unknown for one subject; the remainder were nulliparous (Additional File 1: Table S1). Breast whole transcriptome profiles during adolescence: young women compared with other mammalian species We were motivated to characterize the transcriptome of the ...
Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial This proof-of-concept phase 1 trial shows that the size of circulating tumor cell clusters (which can promote metastatic spread) can be reduced by treatment with the Na+/K+ATPase...
We also use optional cookies for advertising, personalisation of content, usage analysis, and social media. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with...